Insider · CIK 0001368711
Joseph Patrick Cooper
Files at QNRX (Quoin Pharmaceuticals, Ltd.). First filing -, latest -.
Joseph Patrick Cooper files SEC Form 4 as director at QNRX (Quoin Pharmaceuticals, Ltd.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Joseph Patrick Cooper has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +8,141 | $0.00 | $0 | 8,141 | Feb 6, 2026 |
| May 29, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +7,760 | $0.00 | $0 | 7,760 | Jun 2, 2025 |
| Dec 9, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +50,714 | $0.00 | $0 | 50,714 | Dec 10, 2024 |
Questions about Joseph Patrick Cooper
Answered from the filings on this page, as of the latest one.
Is Joseph Patrick Cooper buying or selling?
Joseph Patrick Cooper has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Joseph Patrick Cooper's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joseph Patrick Cooper has 0.
Where does Joseph Patrick Cooper file Form 4?
Joseph Patrick Cooper has filed Form 4 at QNRX (Quoin Pharmaceuticals, Ltd.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.